Ping An Biomedical Co., Ltd.

PASW Consumer Cyclical Textile Manufacturing

Ping An Biomedical Co., Ltd.’s revenue for fiscal 2025 (year ended September 2025) was $4.8 million, down 61.6% from fiscal 2024.

1.34 0.25 −15.72%
Market cap
$4.5M
P/E
—
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
4.30
Beneish M
−2.88
Dividend safety
n/a
Sep '24 Sep '25
Altman Z-Score
— 4.30
Altman Z″-Score (non-manufacturers)
(1.77) 3.50
P/FCF ratio
0.00 0.00
Beneish M-Score
— (2.88)
P/Operating CF
0.00 0.00
P/B ratio
0.00 0.00
EV/Sales
0.00 0.00
EV/EBITDA
0.00 0.00
EV/FCF
0.00 0.00
Current Ratio
0.84 2.76
Net Debt/EBITDA
1,226.75 1.81
Debt/Equity
(1.46) 0.22
ROE
0.00% (67.61%)
ROA
0.00% (20.35%)
ROIC
(0.04%) (49.29%)
Return on Tangible Assets
12.52% (31.58%)
Average Days of Receivables
168.49 180.97
Free Cash Flow Yield
0.00% 0.00%
Free Cash Flow per Share
4.63 (1.95)
Book value per Share
(2.28) 13.76
Free Cash Flow
2.08 (0.90)
EV/EBIT
0.00 0.00
Other line items

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026